Optimal Treatment with Cannabis Extracts Formulations Is Gained via Knowledge of Their Terpene Content and via Enrichment with Specifically Selected Monoterpenes and Monoterpenoids
Differences between therapeutic effects of medical cannabis inflorescences and those of their extracts are generally attributed to the differences in administration form and in the resultant pharmacokinetics. We hypothesized that difference may further extend to the composition of the actually consu...
Main Authors: | Noa Raz, Aharon M. Eyal, Elyad M. Davidson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/20/6920 |
Similar Items
-
Secondary Terpenes in <i>Cannabis sativa</i> L.: Synthesis and Synergy
by: Francisco T. Chacon, et al.
Published: (2022-12-01) -
Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report
by: Noa Raz, et al.
Published: (2022-10-01) -
Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: a proof-of-concept assessment of the Vigil Index of Cannabis Chemovars
by: Jacob Miguel Vigil, et al.
Published: (2023-02-01) -
Acetone as Artifact of Analysis in Terpene Samples by HS-GC/MS
by: Sytze Elzinga, et al.
Published: (2022-09-01) -
Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors
by: David B. Finlay, et al.
Published: (2020-03-01)